Cargando…
Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts
INTRODUCTION: Warts can be resistant to treatment or recur despite the use of various destructive and immunotherapeutic modalities. Combination immunotherapy might contribute to better response rates. The aim of this study was to assess the effectiveness and safety of a triple intralesional immunoth...
Autores principales: | Nofal, Ahmad A., Elkholy, Basma M., Abd-Elmonsef, Esraa R., Nofal, Hagar O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110629/ https://www.ncbi.nlm.nih.gov/pubmed/35449500 http://dx.doi.org/10.1007/s13555-022-00725-x |
Ejemplares similares
-
Switching between intralesional antigens: A promising therapeutic approach for recalcitrant warts
por: Nofal, Ahmad, et al.
Publicado: (2020) -
Intralesional bivalent and quadrivalent human papillomavirus vaccines didn’t significantly enhance the response of multiple anogenital warts when co-administered with intralesional Candida antigen immunotherapy. A randomized controlled trial
por: Fawzy, Manal, et al.
Publicado: (2023) -
Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts?
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2022) -
Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases
por: Al-Qassabi, Al Mutasim, et al.
Publicado: (2022) -
Cidofovir Intralesional Injection for Recalcitrant Common Warts: A Comparison with Sodium Tetradecyl Sulfate Intralesional Injection
por: Oh, Byung Ho
Publicado: (2020)